Federated Hermes’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-556
Closed -$111K 2334
2021
Q3
$111K Sell
556
-1,944
-78% -$493K ﹤0.01% 1762
2021
Q2
$990K Buy
+2,500
New +$884K ﹤0.01% 1324

Other funds holding TBIO

Federated Hermes's TBIO Position: Q4 2021 in Review

Federated Hermes sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q4 2021, closing a stake of 556 shares — an estimated $111K sold.

Federated Hermes first reported a position in TBIO in Q2 2021 and held it in 2 quarters. The position peaked at $990K in Q2 2021. 43 funds tracked by Wall St. Rank hold TBIO as of Q4 2021.

  • Federated Hermes reported no remaining Telesis Bio, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Federated Hermes sold 556 Telesis Bio, Inc. Common Stock shares in Q4 2021, an estimated $111K.
  • Federated Hermes first reported a position in Telesis Bio, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Federated Hermes's Telesis Bio, Inc. Common Stock position peaked at $990K in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q4 2021.

Based on Federated Hermes's 13F filing for Q4 2021, filed 14 Feb 2022.